Contraline vs TIXiMED
Contraline vs TIXiMED, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Contraline is on 48/100 and TIXiMED on 49/100.
Where each one leads
Contraline
- domain rating: 46/100 against 4/100
- funding raised: $103M against $4.8M
TIXiMED
- agent readiness: 55/100 against 21/100
At a glance
| Measure | Contraline | TIXiMED |
|---|---|---|
| What it is | Developing novel male contraceptives. | Clinical-stage pharmaceutical company developing innovative oral therapies for diabetes and metabolic disorders. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Medical Devices | Biotechnology, Pharmaceuticals, HealthTech, Medical Devices |
| Sells toBusiness model | B2B2C | B2B |
| Offering | Hardware | Services |
| Founded | 2017 | 2021 |
| Headquarters | Charlottesville, USA | Birmingham, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Contraline | TIXiMED |
|---|---|---|
| Employees | Not published | 5 |
| Total funding | $103M | $4.8M |
| Latest round | Series B | Seed |
| Valuation | Not published | $1.1B |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Contraline | TIXiMED |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 48/100 | 49/100 |
| Traction | 40/100 | 41/100 |
| Team | Not published | 60/100 |
| Search visibility | 13/100 | 5/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | D (55/100) |
| Domain ratingLink authority, 0-100 | 46/100 | 4/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Contraline | TIXiMED |
|---|---|---|
| Hosting | Not detected | Google Cloud |
Contraline vs TIXiMED: common questions
Which is better, Contraline or TIXiMED?
On our 0-100 score TIXiMED rates higher (49/100 against 48/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Contraline and TIXiMED compare on the numbers?
Contraline leads on domain rating (46/100 against 4/100), funding raised ($103M against $4.8M). TIXiMED leads on agent readiness (55/100 against 21/100).
Read the full Contraline review and pricing or the TIXiMED review and pricing. You can also browse other Contraline alternatives we track.